Sorafenib Impacted Survival Rates in Acute Myeloid Leukemia
The addition of sorafenib to intensive chemotherapy had a significant impact on the survival rate of patients with FLT3-internal tandem duplication mutation-positive acute myeloid leukemia.
Source: CancerNetwork - Category: Cancer & Oncology Authors: Leah Lawrence Source Type: news
More News: Acute Leukemia | Acute Myeloid Leukemia | Cancer & Oncology | Chemotherapy | Legislation | Leukemia